This inventor holds 27 USPTO granted patents and 5 published patent applications and 1 EPO patent, primarily in Amyloid Disease Treatment. Top assignee: New York University. Active years: 2004-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Statent Island, NY (US) (2009)
- Staten Island, NY (US) (2004 - 2022)
Company Filing History:
Years Active: 2004-2026
Areas of Expertise:
Certainly! Here is the article about inventor Thomas M Wisniewski:
Title: Inventor Spotlight: Thomas M Wisniewski - Pioneering Advances in Amyloid Disease Treatment
Introduction:
Thomas M Wisniewski, a distinguished inventor based in Staten Island, NY, has made significant contributions to the field of amyloid disease treatment. With an impressive portfolio of 25 patents, Wisniewski's groundbreaking work focuses on developing innovative therapies to combat amyloid-related disorders.
Latest Patents:
1. "Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides": Wisniewski's invention centers around polymerized products and compositions designed to treat and prevent amyloid disease in patients. This includes isolated antibodies targeting common epitopes of amyloidogenic proteins, crucial for the diagnosis, treatment, and prevention of amyloid diseases.
2. "Preventing and treating amyloid-beta deposition by stimulation of innate immunity": Wisniewski's method involves stimulating the innate immune system to reduce amyloid deposits, addressing cerebral amyloidosis and Alzheimer's Disease. Additionally, he has developed compositions to boost the innate immune response in patients with amyloid deposition symptoms.
Career Highlights:
Currently associated with New York University (NYU), Wisniewski spearheads research and innovation in the field of neurodegenerative diseases. His expertise and leadership have been instrumental in advancing novel treatment modalities for amyloidosis and related conditions.
Collaborations:
Wisniewski collaborates closely with accomplished colleagues such as Fernando Goni and Einar M Sigurdsson. Together, they synergize their efforts to drive forward cutting-edge research and development initiatives aimed at revolutionizing amyloid disease therapeutics.
Conclusion:
In conclusion, Thomas M Wisniewski's unwavering dedication to combating amyloid diseases through innovative patent-backed solutions underscores his status as a trailblazer in the field. His visionary contributions continue to shape the landscape of medical innovation, offering hope to patients and researchers alike in the pursuit of effective treatments for amyloidosis and related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile